NCT Number: NCT00297687
Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults
To determine the safety & immunogenicity of a potential vaccine against meningococcal B disease
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–25 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 1
Primary location
Herson, Queensland, Australia
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Healthy 18-25 year olds
Exclusion criteria
- Prior history of vaccination with any meningococcal vaccine
- Prior history of any invasive meningococcal disease
Treatment and study plan
Primary outcomes
-
Local & systemic safety throughout the trial
Secondary outcomes
-
Evidence of an immune response 1 month after dose 2 & 1 month after dose 3
Sponsors and collaborators
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Industry
Registry information
Official study title
A Randomized, Placebo-Controlled, Double Blind, Phase 1 Trial of the Safety, Immunogenicity, and Tolerability of Ascending Doses of Meningococcal Group B rLP2086 Vaccine in Healthy Adults
Important dates
- Study start
- 2006
- Study completion
- 2007
- First posted
- Feb 28, 2006
- Registry last updated
- Dec 5, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds
NCT03295318
Bacterial Infections, Bacterial Infections and Mycoses
Bamako, Mali
View Trial DetailsA Human Controlled Infection Study with Neisseria Lactamica in Malian Adults
NCT04665791
Bacterial Infections, Bacterial Infections and Mycoses
Bamako, Mali
View Trial DetailsImmunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine
NCT04707391
Bacterial Infections, Bacterial Infections and Mycoses
Jonesboro, Arkansas, United States
View Trial DetailsA Sourcing Study to Collect Human Blood Samples From Healthy Adults
NCT03493919
Bacterial Infections, Bacterial Infections and Mycoses
Sydney, New South Wales, Australia
View Trial Details